Canada markets open in 52 minutes

  • S&P/TSX

    18,320.67
    -100.93 (-0.55%)
     

  • S&P 500

    3,819.72
    -50.57 (-1.31%)
     

  • DOW

    31,270.09
    -121.43 (-0.39%)
     

  • CAD/USD

    0.7911
    +0.0008 (+0.10%)
     

  • CRUDE OIL

    61.58
    +0.30 (+0.49%)
     

  • BTC-CAD

    62,437.50
    -3,357.12 (-5.10%)
     

  • CMC Crypto 200

    989.40
    +2.19 (+0.22%)
     

  • GOLD FUTURES

    1,714.10
    -1.70 (-0.10%)
     

  • RUSSELL 2000

    2,207.79
    -23.72 (-1.06%)
     

  • 10-Yr Bond

    1.4670
    -0.0030 (-0.20%)
     

  • NASDAQ futures

    12,680.50
    -1.25 (-0.01%)
     

  • VOLATILITY

    26.41
    +2.31 (+9.59%)
     

  • FTSE

    6,639.39
    -36.08 (-0.54%)
     

  • NIKKEI 225

    28,930.11
    -628.99 (-2.13%)
     

  • CAD/EUR

    0.6571
    +0.0024 (+0.37%)
     
STOCK MARKET NEWS LIVE UPDATES::

STOCK FUTURES EDGE LOWER

Extending losses after tech-led selloff

Josh Okogie with an assist vs the New Orleans Pelicans

Josh Okogie (Minnesota Timberwolves) with an assist vs the New Orleans Pelicans, 01/23/2021

Latest Stories

  • These 'Fat Activists' Are Fed Up Of Being Part Of The Covid Blame Game

    They've launched a 'day of disruption' to change the narrative this World Obesity Day. Here's what they'll be doing.

  • US jobless claims tick up to 745,000 as layoffs remain high

    The number of Americans applying for unemployment benefits edged higher last week to 745,000, a sign that many employers continue to cut jobs despite a drop in confirmed viral infections and evidence that the overall economy is improving. Thursday's report from the Labor Department showed that jobless claims rose by 9,000 from the previous week. Before the virus flattened the U.S. economy a year ago, applications for unemployment aid had never topped 700,000 in any week, even during the Great Recession.

  • The global micro LED market is expected to reach an estimated $5.3 billion by 2025 with a CAGR of 69%-71% from 2019 to 2025

    Trends, opportunities, and forecast in micro LED market to 2025 by end use industry (consumer electronics, automotive, advertising, aerospace & defense, and others), panel size (micro-displays, small-sized & medium-sized, and large panels), application (display and lighting), and region (North America, Europe, Asia Pacific, and the Rest of the World).New York, March 04, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Micro LED Market Report: Trends, Forecast and Competitive Analysis" - https://www.reportlinker.com/p06030352/?utm_source=GNW According to a new market report, the future of the micro LED market looks promising with opportunities in the consumer electronics, automotive, advertising, and aerospace & defense industries. The global micro LED market is expected to reach an estimated $5.3 billion by 2025 with a CAGR of 69%-71% from 2019 to 2025. The major drivers for this market are growth in smartphones and wearable devices and increasing demand for brighter and better display solutions. Apple Inc, Samsung Electronics, Sony Corporation, Epistar Corporation Lumens, AND Plessy Semiconductor are among the major micro LED manufacturer. The study includes trends and forecast for the global micro LED market by application, panel size, end use industry, and region as follows: By End Use Industry [Value ($M) and Volume (Thousand Units) shipment analysis from 2019 to 2025]: Consumer ElectronicsAutomotiveAdvertisingAerospace and DefenseOthers By Panel Size [Value ($M) and Volume (Thousand Units) shipment analysis from 2019 to 2025]: Micro-DisplaySmall Sized and Medium Sized PanelsLarge Panels By Application [Value ($M) and Volume (Thousand Units) shipment analysis from 2019 to 2025]: DisplayNear to Eye DevicesAR HMDVR HMDSmartphones & TabletsSmartwatchesTelevisionsHead-Up DisplaysMonitors and LaptopsDigital SignageLighting General LightingAutomotive Lighting By Region [Value ($M) and Volume (Thousand Units) shipment analysis for 2019 – 2025]: North AmericaUnited StatesCanadaMexicoEuropeUnited Kingdom GermanyItalyAsia PacificJapanChinaIndiaThe Rest of the World The analyst forecasts that display will remain the largest application segment, and it is also expected to witness the highest growth over the forecast period driven by increasing demand for better display solutions. Within the micro LED market, large panels will remain the largest panel size segment, and the micro display segment is expected to witness the highest growth over the forecast period due to increasing demand for smartphones and wearable devices. Asia Pacific will remain the largest region due to increasing investment by electronics giants in the global micro led market. APAC is also expected to witness the highest growth over the forecast period, supported by increasing demand for consumer electronic devices, such as smartwatches, smart devices, and AR/VR devices, smartphones, televisions, and laptops. Apple Inc, Samsung Electronics, Sony Corporation, Epistar Corporation Lumens, and Plessy Semiconductor are among the major micro LED manufacturers. Features of the Global Micro LED Market Market Size Estimates: Global micro LED market size estimation in terms of value ($M) and volume (Thousand Unites). Trend and Forecast Analysis: Market trends and forecast (2019-2025) by various segments and regions. Segmentation Analysis: Global micro LED market size by various segments, such as end use industry, application, panel size, and region. Regional Analysis: Global micro LED market breakdown by North America, Europe, Asia Pacific, and Rest of the World. Growth Opportunities: Analysis on growth opportunities in different end use industries, applications, panel sizes, and regions for the micro LED market. Strategic Analysis: This includes M&A, new product development, and competitive landscape for the micro LED market. Analysis of competitive intensity of the industry based on Porter’s Five Forces model. This report answers following 11 key questions Q.1 What are some of the most promising, high-growth opportunities for the global micro LED market by end use industry (consumer electronics, automotive, advertisement, aerospace & defense, and others), panel size (micro-displays, small-sized & medium-sized, and large panels), application (display and lighting), and region (North America, Europe, Asia Pacific, and the Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which regions will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the market? Q.5 What are the business risks and threats to the market? Q.6 What are the emerging trends in this market and the reasons behind them? Q.7 What are some changing demands of customers in the market? Q.8 What are the new developments in the micro LED market? Which companies are leading these developments? Q.9 Who are the major players in this market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this market, and how big of a threat do they pose for loss of market share via product substitution? Q.11 What M&A activity did occur in the last five years in this market?Read the full report: https://www.reportlinker.com/p06030352/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

  • GB skipper Jodie Williams aiming for medals at European Indoor Championships

    Sprinter Williams has been named Great Britain’s captain for the European Indoor Championships.

  • Form 8.3 -Willis Towers Watson plc

    FORM 8.3IRISH TAKEOVER PANELDISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE1. KEY INFORMATIONName of person dealing (Note 1)State Street Global Advisors & AffiliatesCompany dealt inWillis Towers Watson plc.Class of relevant security to which the dealings being disclosed relate (Note 2)US$0.000304635 ordinary sharesDate of dealing03rd March 2021 2. INTERESTS AND SHORT POSITIONS(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) LongShort Number(%)Number(%)(1) Relevant securities6,333,742 4.91100% (2) Derivatives (other than options)N/A (3) Options and agreements to purchase/sellN/A Total6,333,742 4.91100% (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)Class of relevant security:LongShort Number(%)Number(%)(1) Relevant securitiesN/A (2) Derivatives (other than options)N/A (3) Options and agreements to purchase/sellN/A TotalN/A 3. DEALINGS (Note 4)(a) Purchases and salesPurchase/saleNumber of relevant securitiesPrice per unit (Note 5)Purchase1,520222.65Purchase8,512222.65Purchase5,684222.65Purchase1,044222.65Purchase12,760222.65Purchase1,450222.65Purchase270222.65Purchase18222.65Purchase36222.65Purchase18222.65Purchase3222.65Purchase18222.65Purchase252222.65Purchase84222.65Sale2,400224.11Sale16222.65Sale638222.65Sale60222.65Sale170222.65 (b) Derivatives transactions (other than options transactions)Product name, e.g. CFDNature of transaction (Note 6)Number of relevant securities (Note 7)Price per unit (Note 5)N/A (c) Options transactions in respect of existing relevant securities(i) Writing, selling, purchasing or varyingProduct name, e.g. call optionWriting, selling, purchasing varying etc.Number of securities to which the option relates (Note 7)Exercise priceType, e.g. American, European etc.Expiry dateOption money paid/received per unit (Note 5)N/A (ii) ExercisingProduct name, e.g. call optionNumber of securitiesExercise price per unit (Note 5)N/A (d) Other dealings (including transactions in respect of new securities) (Note 4)Nature of transaction (Note 8)DetailsPrice per unit (if applicable) (Note 5)N/A 4. OTHER INFORMATIONAgreements, arrangements or understandings relating to options or derivativesFull details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.N/AIs a Supplemental Form 8 attached? (Note 9)NO Date of disclosure04th March 2021 Contact nameLionel ColacoTelephone number 020 33956098If a connected EFM, name of offeree/offeror with which connectedN/AIf a connected EFM, state nature of connection (Note 10)N/A

  • Astronics Selected to Manufacture Components for the Raytheon Missiles & Defense Light Weight Command Launch Unit (CLU) for the Javelin Program

    Astronics Selected to Manufacture components for the Raytheon Missiles & Defense Light Weight Command Launch Unit (CLU) for the Javelin Program

  • Wynnchurch Capital Acquires Northern Wholesale Supply

    Wynnchurch Capital, L.P. ("Wynnchurch") announced today that it has acquired Northern Wholesale Supply, LLC ("NWS" or the "Company"). NWS is a leading distributor of marine and RV accessories. Founded in 1984, NWS is an industry leader providing an all-encompassing suite of over 30,000 parts and accessories. The Company also maintains a proprietary products division (primarily comprised of its Extreme Max® product line) to address unmet customer demand. NWS currently serves its customers throughout the U.S. from its headquarters in Hugo, Minnesota.

  • Court drops case against Dutch father who isolated family

    THE HAGUE, Netherlands — A Dutch court ruled Thursday that a deeply religious father who kept some of his children isolated from the outside world for years in a remote farmhouse can't stand trial on charges including child sexual abuse because he has been incapacitated by a stroke. The decision came after prosecutors last month asked the court in the northern city of Assen to drop the case because the 68-year-old suspect wasn't fit to stand trial. Prosecutors had initially accused him of illegally detaining his children and sexually abusing two of them when they were under age 16. It brings to an end a case that made headlines around the world in October 2019 after one of the man's sons raised the alarm and authorities discovered the father had been living for years with six of his children in the farmhouse in the small village of Ruinerwold in the eastern Netherlands. At a preliminary hearing in January last year, prosecutors portrayed the father, identified only as Gerrit Jan van D., as a deeply religious man who saw his family as “chosen by God” and did everything in his power — including physical beatings and other punishments — to keep them from succumbing to what he considered malign outside influences. Aerial images of the farm showed it surrounded by hedges and trees and with a large vegetable patch near the buildings. The court ruled Thursday that a 2016 stroke had so badly affected the father's ability to communicate and comprehend that continuing with the case would breach his fair trial rights. “He doesn't sufficiently understand what is happening in the courtroom,” court spokesman Marcel Wolters said in a video statement. The six children who were kept on the farm are now all young adults. Three older siblings had earlier left the family’s isolated life. Their mother died in 2004. It wasn't immediately clear what will now happen to the father. An Austrian national identified only as Jozef B., who is accused of helping the father keep the family in isolation, remains a suspect in the case. Corinne Jeekel, a lawyer representing the eldest four children, told Dutch broadcaster NOS that they were disappointed with the decision. “It is a great shame for the clients that there will be no criminal judgment” on the allegations, Jeekel told national broadcaster NOS. The rest of the family, however, stood by their father. “The youngest five children are very happy,” defence lawyer Robert Snorn told local broadcaster RTV Drenthe. Prosecutors said last month that the children are now free to choose their own futures, even if that means returning to a life of isolation. “In the past 18 months, the children have got to know our society, have been able to participate in it and have received spiritual and medical care,” prosecutors said in a statement. “If, now that they have been able to taste the alternative, they nevertheless choose to want to live in seclusion with their father again, to exercise their faith ... that is their choice.” Mike Corder, The Associated Press

  • South American World Cup qualifiers in doubt as clubs take hard line

    This month's World Cup qualifiers in South America are in serious doubt, with European clubs unlikely to release their players to travel amid concern over the COVID-19 pandemic and quarantine restrictions. World soccer's governing body FIFA has relaxed its normal rules about player-release for internationals because of the pandemic and worries about the impact of long-distance travel to areas with high case-rates. All 10 South American countries feature on the UK government's "red list" travel ban, which does not include exemptions for athletes and sports people.

  • UK competition watchdog investigates Apple's App Store

    U.K. authorities have launched an investigation into Apple's App Store over concerns it has a dominant role that stifles competition and hurts consumers. The Competition and Markets Authority said Thursday it was looking into “suspected breaches of competition law" by Apple. The announcement adds to regulatory scrutiny of the iPhone maker's app distribution platform, which is also the subject of three antitrust probes by the European Union's executive Commission.

  • Loyalists pull support for NI peace deal over Brexit rules

    Outlawed Loyalist paramilitary groups in Northern Ireland say they are temporarily withdrawing their support for the historic 1998 peace accord because of the disruption caused by new post-Brexit trade rules. The Loyalist Communities Council, which represents several banned paramilitary groupings, said in a letter to Prime Minister Boris Johnson that the new trade rules undermined the basis of Northern Ireland’s 1998 Good Friday accord, and they would no longer support it until there was “unfettered access for goods, services, and citizens throughout the United Kingdom.” Jeffrey Donaldson, a lawmaker with Northern Ireland’s Democratic Unionist Party, said Thursday that there was “no sense that loyalist paramilitaries were going to revert to violence in opposition to the Northern Ireland Protocol.”

  • Bioanalytical Systems, Inc., doing business as Inotiv, to Participate in the H.C. Wainwright Global Life Sciences Virtual Conference

    WEST LAFAYETTE, Ind., March 04, 2021 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (the “Company”, “We”, “Our” or “Inotiv”), doing business as Inotiv, a leading provider of nonclinical and analytical contract research services, today announced that Robert Leasure, Jr., President and Chief Executive Officer, and Beth Taylor, Vice President of Finance and Chief Financial Officer, are scheduled to participate in the H.C. Wainwright Global Life Sciences Virtual Conference on March 9-10, 2021. Management will be available for one-on-one meetings throughout both days. A webcast of the presentation will be available on March 9, 2021, at 7:00 a.m. ET through a link that will be posted on the Investors section of the Company’s website at ir.inotivco.com and will be available for approximately 90 days. About the Company Bioanalytical Systems, Inc., doing business as Inotiv, is a pharmaceutical development company providing contract research services and monitoring instruments to emerging pharmaceutical companies and the world's leading drug development companies and medical research organizations. The Company focuses on developing innovative services supporting its clients’ discovery and development objectives for improved decision-making and accelerated goal attainment. The Company’s products focus on increasing efficiency, improving data, and reducing the cost of taking new drugs to market. Visit inotivco.com for more information about the Company. This press release contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties. Forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to update any of them publicly in light of new information or future events. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors. More information, including potential risk factors, that could affect the Company’s business and financial results are included in the Company’s filings with the U.S. Securities and Exchange Commission, including, but not limited to, the Company’s Forms 10-K, 10-Q and 8-K. Company ContactInvestor RelationsBioanalytical Systems, Inc., dba InotivThe Equity Group Inc.Beth A. Taylor, Chief Financial OfficerKalle Ahl, CFA(765) 497-8381(212) 836-9614btaylor@inotivco.comkahl@equityny.com Devin Sullivan (212) 836-9608 dsullivan@equityny.com

  • DeepSpatial Inc. to Begin Trading on CSE on March 4th, 2021 Under Ticker Symbol (CSE: DSAI)

    DeepSpatial Inc. to Begin Trading on CSE on March 4th, 2021 Under Ticker Symbol (CSE: DSAI)

  • ‘Fifth of terror prisoners are right-wing extremists’

    Home Office figures show that 42 out of 209 prisoners in 2020 were classed as holding ‘extreme right-wing’ views.

  • UPDATE 1-Turquoise Hill says CEO Ulf Quellmann resigns amid Rio Tinto pressure

    Turquoise Hill Resources Ltd said on Thursday Chief Executive Officer Ulf Quellmann has resigned after top shareholder Rio Tinto told the Canadian miner it plans to vote against his re-election. The company said it has appointed Steeve Thibeault as interim CEO. Turquoise Hill has been locked in a feud with Anglo-Australian miner Rio Tinto Plc, which holds 51% of the company, over the underground expansion of the massive Oyu Tolgoi copper mine in Mongolia, in which Turquoise owns a 66% stake.

  • Supreme Court reserves order on Mukhtar Ansari's transfer to Uttar Pradesh from Punjab jail

    While Uttar Pradesh alleged in the apex court that there is collusion between Ansari and Punjab Police, the Amarinder Singh government refuted these claims and raised questions over the maintainability of plea filed by the Yogi Adityanath-led government

  • US suspends tariffs on single malt Scotch whisky

    The suspension, which includes other goods, covers tariffs that were imposed in a row over Airbus subsidies.

  • IAA Announces New Kansas City East Location

    IAA, Inc. (NYSE: IAA), a leading global digital marketplace connecting vehicle buyers and sellers, announces a new branch location in the growing Kansas City market. The location will be the second branch in the area and will help accommodate increased customer capacity needs.

  • Notification of Major Holdings

    TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:G4S plc1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate)Non-UK issuer 2. Reason for the notification (please mark the appropriate box or boxes with an “X”)An acquisition or disposal of voting rightsXAn acquisition or disposal of financial instruments An event changing the breakdown of voting rights Other (please specify)iii: 3. Details of person subject to the notification obligationivNameSkandinaviska Enskilda Banken AB (publ)City and country of registered office (if applicable)Stockholm, Sweden4. Full name of shareholder(s) (if different from 3.)vName City and country of registered office (if applicable) 5. Date on which the threshold was crossed or reachedvi:03/03/20216. Date on which issuer notified (DD/MM/YYYY):04/03/20217. Total positions of person(s) subject to the notification obligation % of voting rights attached to shares (total of 8. A)% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)Total of both in % (8.A + 8.B)Total number of voting rights held in issuerviiResulting situation on the date on which threshold was crossed or reached6.091 %06.091 %1551594436Position of previous notification (if applicable)5.92067 %05.92067 % 8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviiiA: Voting rights attached to sharesClass/type of sharesISIN code (if possible)Number of voting rightsix% of voting rightsDirect(DTR5.1)Indirect (DTR5.2.1)Direct(DTR5.1)Indirect(DTR5.2.1)GB00B01FLG629450581219006.090880.00012 SUBTOTAL 8. A945077126.091 B 1: Financial Instruments according to DTR5.3.1R (1) (a)Type of financial instrumentExpiration datexExercise/ Conversion PeriodxiNumber of voting rights that may be acquired if the instrument is exercised/converted.% of voting rights SUBTOTAL 8. B 1 B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)Type of financial instrumentExpiration datexExercise/ Conversion Period xiPhysical or cash settlementxiiNumber of voting rights % of voting rights SUBTOTAL 8.B.2 9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an “X”)Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)XNamexv% of voting rights if it equals or is higher than the notifiable threshold% of voting rights through financial instruments if it equals or is higher than the notifiable thresholdTotal of both if it equals or is higher than the notifiable thresholdSkandinaviska Enskilda Banken AB (publ)6.0908806.09088SEB Life International Assurance Company0.0001200.00012 10. In case of proxy voting, please identify:Name of the proxy holder The number and % of voting rights held The date until which the voting rights will be held 11. Additional informationxvi Place of completionRiga, LatviaDate of completion04/03/2021

  • ARCH Scientist Publishes Paper Showing Pre-Clinical Efficacy of AB569 in Eradicating Multi-Drug Resistant Pathogens Acinetobacter baumannii and Acinetobacter spp

    TORONTO, March 04, 2021 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that one of its lead scientists, Dr. Daniel Hassett, Professor at the University of Cincinnati College of Medicine, published a paper entitled “AB569, A Non-toxic Combination of Acidified Nitrite and EDTA, is Effective at Killing the Notorious Iraq/Afghanistan Combat Wound Pathogens, Multi-Drug Resistant Acinetobacter baumannii and Acinetobacter spp.” in the journal PloS One. Dr. Hassett invented AB569 at the University of Cincinnati College of Medicine. Dr. Hassett, who collaborated with both the United States Air Force and Arch, demonstrated that AB569 kills multi-drug resistant strains of Acinetobacter baumannii and Acinetobacter spp. bacteria. These pathogens have been shown to infect soldiers who are injured by gun, shrapnel, burn or blast wounds. Nearly 40 multi-drug resistant strains of these organisms were obtained from Dr. Edwin Kamau, M.D., Chief of Molecular Diagnostics at Walter Reed Army Institute of Research (Silver Springs, MD). Acinetobacter baumannii has been colloquially referred to in the literature as "Iraqibacter", as it has emerged in a myriad of military clinics and has drastically spread to civilian hospital clinics due to transport of infected combat soldiers. The full publication can be viewed at: https://pubmed.ncbi.nlm.nih.gov/33657146/ “Despite the attention on the current COVID-19 pandemic, the pandemic of antibiotic resistance has been ongoing for more than 50 years and will continue to loom large in human health. Sadly, the discovery of new antimicrobial drugs has slowed to a trickle. Thus, there is still an urgent need for the development of novel, cutting-edge drugs such as AB569 to help solve this deadly and costly global health problem,” said, Dr. Hassett. Clinical Opportunity for Arch to Develop AB569 Arch is currently exploring new opportunities to sponsor a human trial to prevent, treat, and heal wound infections using an AB569 topical cream or gel. Similar clinical opportunities to test the AB569 wound cream exist in targeting abscesses, diabetic wounds and skin ulcers. Future clinical developments may also involve using AB569 for problematic infections involving the urinary tract as well as bacterial lung infections that are a hallmark of Cystic Fibrosis and chronic obstructive pulmonary disease (COPD) airway disease. About AB569 AB569 is a synergistic antimicrobial tandem of slightly acidified sodium nitrite and EDTA that has the critical advantage over conventional antibiotics in that it down regulates many of the genes in the bacterium responsible for survival. In a recent publication in the prestigious Proceedings of the National Academy of Sciences, Dr. Hassett’s group showed that AB569 caused a catastrophic loss of the capacity to support vital core biosynthetic and metabolic pathways of another multi-drug resistant pathogen, Pseudomonas aeruginosa. These include the synthesis of DNA, RNA, protein, ATP and the ability of bacteria to breathe by both aerobic and anaerobic respiration. About Arch Biopartners Arch Biopartners Inc. is a clinical stage company focused on the development of innovative technologies that have the potential to make a significant medical or commercial impact. Arch is developing a pipeline of new drug candidates that inhibit inflammation in the lungs, liver and kidneys via the dipeptidase-1 (DPEP-1) pathway for multiple medical indications. Continuing under development in the Arch portfolio are: AB569, a potential new treatment for antibiotic resistant bacterial infections in the lung, wounds and urinary tract; and, ‘Borg’ peptide coatings that increase corrosion resistance and decrease bacterial biofilm on various medical grade metals and plastics. For more information on Arch Biopartners, its technologies and other public documents Arch has filed on SEDAR, please visit www.archbiopartners.com. The Company has 61,362,302 common shares outstanding. Forward-Looking Statements All statements, other than statements of historical fact, in this news release are forward looking statements that involve various risks and uncertainties, including, without limitation, statements regarding the future plans and objectives of the Company. There can be no assurance that such statements will prove to be accurate. Actual results and future events could differ materially from those anticipated in such statements. These and all subsequent written and oral forward-looking statements are based on the estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. The Company assumes no obligation to update forward-looking statements should circumstances or management’s estimates or opinions change. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release CONTACT: For more information, please contact: Richard Muruve Chief Executive Officer Arch Biopartners, Inc. 647-428-7031 info@archbiopartners.com